#United States #Trulieve Cannabis #Tallahassee #investor events #Cannabis Corp

Trulieve to Showcase at Upcoming Investor Conferences in September 2026

Trulieve Cannabis Corp., a standout player in the U.S. medical cannabis sector, has made headlines with its announcement regarding participation in two significant investor conferences happening in September 2026. As a leading medical cannabis company, Trulieve is expected to leverage these events to connect with investors and showcase its industry advancements.

Event Details

The two key conferences where Trulieve will be represented are:

1. ATB Cormark Capital Markets 2026 Fall Institutional Investor Conference
- Date: September 9, 2026
- Presenter: Christine Hersey, Chief Corporate Affairs and Strategy Officer

2. 5th Annual Roth Healthcare Opportunities Conference
- Date: September 29, 2026
- Presenter: Kim Rivers, Founder and CEO

During these events, both Christine Hersey and Kim Rivers will partake in various investor meetings, emphasizing Trulieve's commitment to enhancing its stakeholder relationships and attracting further investments.

About Trulieve

Trulieve Cannabis Corp. operates as a vertically integrated cannabis company, managing a vast network of medical marijuana operations across several states, including Florida, Georgia, Pennsylvania, and West Virginia. The company's mission revolves around expanding access to cannabis while delivering high-quality branded products and exceptional customer experiences.

With a robust operational structure and strategic growth initiatives guided by their hub strategy, Trulieve has positioned itself for substantial growth in the evolving cannabis market. As a publicly traded entity listed on the New York Stock Exchange under the ticker symbol TRLV, Trulieve continues to enhance its reputation within the industry as a top-performing medical cannabis company.

Commitment to Shareholders

Trulieve remains dedicated to transparency and engagement with its shareholders. The upcoming conferences not only provide an opportunity for the company's leaders to share insights about Trulieve's operational achievements but also to discuss future growth prospects. Investors can look forward to gaining valuable insights into the company's innovative strategies and market position.

For those interested in more information about the events and Trulieve’s ongoing initiatives, the company encourages visiting their investor relations page at Trulieve Investor Events. The page offers updates, access to event slides, and an overview of the company’s performance and strategic goals.

Conclusion

Trulieve's involvement in the September 2026 investor conferences underscores its proactive approach to stakeholder engagement in an ever-competitive medical cannabis industry. As the company continues to expand its footprint in key markets, it looks to foster strong relationships with investors while delivering exceptional products and services to its customers. The insights shared at these conferences could mark a pivotal point in Trulieve's growth trajectory and investor relations strategy.